Discovery of a known MEN2 pathogenic RET mutation within a family leads to screening for MTC, pheochromocytomas, or parathyroid hyperplasia, and potentially prophylactic thyroidectomy to increase survival rate for the intractable, aggressive MTC. The gene discussed is RET; the disease is parathyroid hyperplasia.